LncRNA SNHG25 Predicts Poor Prognosis and Promotes Progression in Osteosarcoma via the miR-497-5p/SOX4 Axis


Дәйексөз келтіру

Толық мәтін

Аннотация

Background:Osteosarcoma is a disease that primarily affects adolescents with skeletal immaturity. LncRNAs are abnormally expressed and correlated with osteosarcoma patients' prognosis. We identified aberrant expression of LncRNA SNHG25 (small nucleolar RNA host gene 25) in osteosarcoma and analyzed the molecular mechanisms by which it regulates osteosarcoma progression.

Methods:The expression levels of SNHG25 in tumour specimens and cells were measured by RTqPCR. Loss-of-function assays were conducted to investigate the functional role of SNHG25 in vitro and in vivo. Bioinformatic predictions, dual-luciferase reporter assays, and western blotting were performed to explore the possible underlying mechanisms.

Results:SNHG25 was highly expressed in osteosarcoma cells and tissues. The Kaplan–Meier curve showed that the survival rate of patients with high SNHG25 expression was significantly lower than those with low SNHG25 expression. Functional studies have indicated that inhibition of SNHG25 suppresses cell proliferation, migration, and invasion, while promoting apoptosis. SNHG25 knockdown suppresses osteosarcoma tumour growth in vivo. SNHG25 functions as a sponge for miR-497-5p in osteosarcoma cells. The level of SNHG25 was negatively correlated with that of miR-497-5p. The proliferation, invasion, and migration of osteosarcoma cells were restored by transfection of the miR-497-5p inhibitor in the SNHG25 knockdown group

Conclusion:SNHG25 was determined to function as an oncogene by promoting osteosarcoma cell proliferation, invasion, and migration through the miR-497-5p/SOX4 axis. Upregulation of SNHG25 expression indicated poor prognosis in patients with osteosarcoma, which showed that SNHG25 may serve as a potential therapeutic target and prognostic biomarker in osteosarcoma.

Авторлар туралы

Ningjun Wan

, Ningxia Medical University

Email: info@benthamscience.net

Qiang Liu

, Ningxia Medical University

Email: info@benthamscience.net

Jiandang Shi

Department of Orthopedics, General Hospital of Ningxia Medical University

Хат алмасуға жауапты Автор.
Email: info@benthamscience.net

Siliang Wang

, Ningxia Medical University

Email: info@benthamscience.net

Әдебиет тізімі

  1. Cole, S.; Gianferante, D.M.; Zhu, B.; Mirabello, L. Osteosarcoma: A surveillance, epidemiology, and end results program-based analysis from 1975 to 2017. Cancer, 2022, 128(11), 2107-2118. doi: 10.1002/cncr.34163 PMID: 35226758
  2. Smeland, S.; Bielack, S.S.; Whelan, J.; Bernstein, M.; Hogendoorn, P.; Krailo, M.D.; Gorlick, R.; Janeway, K.A.; Ingleby, F.C.; Anninga, J.; Antal, I.; Arndt, C.; Brown, K.L.B.; Butterfass-Bahloul, T.; Calaminus, G.; Capra, M.; Dhooge, C.; Eriksson, M.; Flanagan, A.M.; Friedel, G.; Gebhardt, M.C.; Gelderblom, H.; Goldsby, R.; Grier, H.E.; Grimer, R.; Hawkins, D.S.; Hecker-Nolting, S.; Sundby Hall, K.; Isakoff, M.S.; Jovic, G.; Kühne, T.; Kager, L.; von Kalle, T.; Kabickova, E.; Lang, S.; Lau, C.C.; Leavey, P.J.; Lessnick, S.L.; Mascarenhas, L.; Mayer-Steinacker, R.; Meyers, P.A.; Nagarajan, R.; Randall, R.L.; Reichardt, P.; Renard, M.; Rechnitzer, C.; Schwartz, C.L.; Strauss, S.; Teot, L.; Timmermann, B.; Sydes, M.R.; Marina, N. Survival and prognosis with osteosarcoma: Outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort. Eur. J. Cancer, 2019, 109, 36-50. doi: 10.1016/j.ejca.2018.11.027 PMID: 30685685
  3. Harrison, D.J.; Geller, D.S.; Gill, J.D.; Lewis, V.O.; Gorlick, R. Current and future therapeutic approaches for osteosarcoma. Expert Rev. Anticancer Ther., 2018, 18(1), 39-50. doi: 10.1080/14737140.2018.1413939 PMID: 29210294
  4. Cates, J.M.M. Modeling continuous prognostic factors in survival analysis: Implications for tumour staging and assessing chemotherapy effect in osteosarcoma. Am. J. Surg. Pathol., 2018, 42(4), 485-491. doi: 10.1097/PAS.0000000000000995 PMID: 29200101
  5. Mirabello, L.; Troisi, R.J.; Savage, S.A. Osteosarcoma incidence and survival rates from 1973 to 2004. Cancer, 2009, 115(7), 1531-1543. doi: 10.1002/cncr.24121 PMID: 19197972
  6. Jandura, A.; Krause, H.M. The new RNA world: Growing evidence for long noncoding RNA functionality. Trends Genet., 2017, 33(10), 665-676. doi: 10.1016/j.tig.2017.08.002 PMID: 28870653
  7. Harrison, P.M.; Khachane, A.; Kumar, M. Genomic assessment of the evolution of the prion protein gene family in vertebrates. Genomics, 2010, 95(5), 268-277. doi: 10.1016/j.ygeno.2010.02.008 PMID: 20206252
  8. Ji, Z.; Qiu, Y.; Cai, Q.; Xu, C. LINC00922 acts as a novel oncogene in gastric cancer. World J. Surg. Oncol., 2022, 20(1), 121. doi: 10.1186/s12957-022-02569-3 PMID: 35428261
  9. Liu, T.; Liao, S.; Mo, J.; Bai, X.; Li, Y.; Zhang, Y.; Zhang, D.; Cheng, R.; Zhao, N.; Che, N.; Guo, Y.; Dong, X.; Zhao, X. LncRNA n339260 functions in hepatocellular carcinoma progression via regulation of miRNA30e-5p/TP53INP1 expression. J. Gastroenterol., 2022, 57(10), 784-797. doi: 10.1007/s00535-022-01901-8 PMID: 35802258
  10. Song, Y.; Liang, Y.; Zou, Q.; Zeng, S.; Lin, H.; Liu, M.; Liu, X.; Du, J.; Chen, G.; Zou, L.; Su, W.; Niu, F. LINC00857 promotes the proliferation of pancreatic cancer via MET, STAT3, and CREB. J. Gastrointest. Oncol., 2021, 12(6), 2622-2630. doi: 10.21037/jgo-21-723 PMID: 35070392
  11. Zhou, S.; Yu, L.; Xiong, M.; Dai, G. LncRNA SNHG12 promotes tumorigenesis and metastasis in osteosarcoma by upregulating Notch2 by sponging miR-195-5p. Biochem. Biophys. Res. Commun., 2018, 495(2), 1822-1832. doi: 10.1016/j.bbrc.2017.12.047 PMID: 29229388
  12. Wang, Z.; Wang, Z.; Liu, J.; Yang, H. Long non-coding RNA SNHG5 sponges miR-26a to promote the tumorigenesis of osteosarcoma by targeting ROCK1. Biomed. Pharmacother., 2018, 107, 598-605. doi: 10.1016/j.biopha.2018.08.025 PMID: 30114643
  13. Liu, Y.; Xu, B.; Liu, M.; Qiao, H.; Zhang, S.; Qiu, J.; Ying, X. Long non-coding RNA SNHG25 promotes epithelial ovarian cancer progression by up-regulating COMP. J. Cancer, 2021, 12(6), 1660-1668. doi: 10.7150/jca.47344 PMID: 33613753
  14. He, Y.; Xu, S.; Qi, Y.; Tian, J.; Xu, F. Long noncoding RNA SNHG25 promotes the malignancy of endometrial cancer by sponging microRNA-497-5p and increasing FASN expression. J. Ovarian Res., 2021, 14(1), 163. doi: 10.1186/s13048-021-00906-w PMID: 34789312
  15. Chen, L.L. Linking long noncoding RNA localization and function. Trends Biochem. Sci., 2016, 41(9), 761-772. doi: 10.1016/j.tibs.2016.07.003 PMID: 27499234
  16. Conte, F.; Fiscon, G.; Sibilio, P.; Licursi, V.; Paci, P. An overview of the computational models dealing with the regulatory ceRNA mechanism and ceRNA deregulation in cancer. Methods Mol. Biol., 2021, 2324, 149-164. doi: 10.1007/978-1-0716-1503-4_10 PMID: 34165714
  17. Yao, Q.; Li, Y.; Pei, Y.; Xie, B. Long non-coding RNA taurine up regulated 1 promotes osteosarcoma cell proliferation and invasion through upregulating Ezrin expression as a competing endogenous RNA of micro RNA-377-3p. Bioengineered, 2022, 13(1), 1767-1778. doi: 10.1080/21655979.2021.1995578 PMID: 35012433
  18. Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004, 116(2), 281-297. doi: 10.1016/S0092-8674(04)00045-5 PMID: 14744438
  19. Sampson, V.B.; Yoo, S.; Kumar, A.; Vetter, N.S.; Kolb, E.A. MicroRNAs and potential targets in osteosarcoma. Front Pediatr., 2015, 3, 69. doi: 10.3389/fped.2015.00069 PMID: 26380245
  20. Jackson, R.J.; Standart, N. How do microRNAs regulate gene expression? Sci. STKE, 2007, 2007(367), re1. doi: 10.1126/stke.3672007re1 PMID: 17200520
  21. Sun, Z.; Li, A.; Yu, Z.; Li, X.; Guo, X.; Chen, R. MicroRNA-497-5p suppresses tumour cell growth of osteosarcoma by targeting ADP Ribosylation Factor-Like Protein 2. Cancer Biother. Radiopharm., 2017, 32(10), 371-378. doi: 10.1089/cbr.2017.2268 PMID: 29265919
  22. Chen, B.; Zhao, X.; Li, X.; Liu, J.; Tang, J. Fatal heart disease in patients with bone and soft tissue sarcoma. Front. Cardiovasc. Med., 2022, 9, 951940. doi: 10.3389/fcvm.2022.951940 PMID: 36312272
  23. Ritter, J.; Bielack, S.S. Osteosarcoma. Ann. Oncol., 2010, 21(S7), vii320-vii325. doi: 10.1093/annonc/mdq276 PMID: 20943636
  24. Wang, Z.; Wei, Y.; Zhu, H.; Yu, L.; Zhu, J.; Han, Q.; Liu, Z.; Huang, J.; Zhu, Y.; Fan, G.; Tang, Q.; Qian, J.; Chen, X.; Zhou, G. LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p. BMC Cancer, 2022, 22(1), 728. doi: 10.1186/s12885-022-09833-5 PMID: 35787258
  25. Wang, B.; Xu, Z.; Wang, X.; Xia, S.; Cai, P.; Wang, M.; Gao, Z. Knockdown of lncRNA LINC00662 suppresses malignant behaviour of osteosarcoma cells via competition with miR-30b-3p to regulate ELK1 expression. J. Orthop. Surg. Res., 2022, 17(1), 74. doi: 10.1186/s13018-022-02964-2 PMID: 35123530
  26. Chen, T.; Liu, J.; Zhang, H.; Li, J.; Shang, G. Long intergenic noncoding RNA00265 enhances cell viability and metastasis via targeting miR-485-5p/USP22 axis in osteosarcoma. Front. Oncol., 2022, 12, 907472. doi: 10.3389/fonc.2022.907472 PMID: 35692754
  27. Deng, R.; Zhang, J.; Chen, J. lncRNA SNHG1 negatively regulates miRNA 101 3p to enhance the expression of ROCK1 and promote cell proliferation, migration and invasion in osteosarcoma. Int. J. Mol. Med., 2018, 43(3), 1157-1166. doi: 10.3892/ijmm.2018.4039 PMID: 30592267
  28. Ju, C.; Zhou, R.; Sun, J.; Zhang, F.; Tang, X.; Chen, K.K.; Zhao, J.; Lan, X.; Lin, S.; Zhang, Z.; Lv, X.B. LncRNA SNHG5 promotes the progression of osteosarcoma by sponging the miR-212-3p/SGK3 axis. Cancer Cell Int., 2018, 18(1), 141. doi: 10.1186/s12935-018-0641-9 PMID: 30250399
  29. Wang, X.; Hu, K.; Chao, Y.; Wang, L. LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis. Biomed. Pharmacother., 2019, 114, 108798. doi: 10.1016/j.biopha.2019.108798 PMID: 30909141
  30. Wang, W.; Luo, P.; Guo, W.; Shi, Y.; Xu, D.; Zheng, H.; Jia, L. LncRNA SNHG20 knockdown suppresses the osteosarcoma tumorigenesis through the mitochondrial apoptosis pathway by miR-139/RUNX2 axis. Biochem. Biophys. Res. Commun., 2018, 503(3), 1927-1933. doi: 10.1016/j.bbrc.2018.07.137 PMID: 30072099
  31. Bi, J.; Guo, Y.; Li, Q.; Liu, L.; Bao, S.; Xu, P. Role of long intergenic non-protein coding RNA 01857 in hepatocellular carcinoma malignancy via the regulation of the microRNA-197-3p/anterior GRadient 2 axis. PLoS One, 2021, 16(11), e0258312. doi: 10.1371/journal.pone.0258312 PMID: 34793477
  32. Wu, H.; Dong, D.; Wang, J.; Yin, S.; Gong, Y.; Yang, C.; Bai, Y.; Wang, J.; Du, Y. LncRNA NEAT1 promotes the malignant progression of colorectal cancer by targeting ZEB1 via miR-448. Technol. Cancer Res. Treat., 2022, 21, 15330338221085348. doi: 10.1177/15330338221085348 PMID: 35695254
  33. Wang, J.; Shi, P.; Teng, H.; Lu, L.; Guo, H.; Wang, X.; Wang, X. LncRNA DCST1-AS1 promotes endometrial cancer progression by modulating the MiR-665/HOXB5 and MiR-873-5p/CADM1 pathways. Front. Oncol., 2021, 11, 714652. doi: 10.3389/fonc.2021.714652 PMID: 34497766
  34. Ma, W.; Gao, Y.; Zhang, J.; Yao, X.; Jia, L.; Xu, Q. Long noncoding RNA LINC01410 promotes tumorigenesis of osteosarcoma cells via miR‐497‐5p/HMGA2 axis. J. Biochem. Mol. Toxicol., 2021, 35(12), e22921. doi: 10.1002/jbt.22921 PMID: 34605103
  35. Moreno, C.S. SOX4: The unappreciated oncogene. Semin. Cancer Biol., 2020, 67(Pt. 1), 57-64. doi: 10.1016/j.semcancer.2019.08.027 PMID: 31445218
  36. Chen, H.; Liu, T.; Ouyang, H.; Lin, S.; Zhong, H.; Zhang, H.; Yang, Y. Upregulation of FTX promotes osteosarcoma tumourigenesis by increasing SOX4 expression via miR-214-5p. OncoTargets Ther., 2020, 13, 7125-7136. doi: 10.2147/OTT.S238070 PMID: 32821116
  37. Li, G.; Liu, K.; Du, X. Long non-Coding RNA TUG1 promotes proliferation and inhibits apoptosis of osteosarcoma cells by sponging miR-132-3p and upregulating SOX4 expression. Yonsei Med. J., 2018, 59(2), 226-235. doi: 10.3349/ymj.2018.59.2.226 PMID: 29436190
  38. Chen, D.; Hu, C.; Wen, G.; Yang, Q.; Zhang, C.; Yang, H. DownRegulated SOX4 expression suppresses cell proliferation, migration, and induces apoptosis in osteosarcoma in vitro and in vivo. Calcif. Tissue Int., 2018, 102(1), 117-127. doi: 10.1007/s00223-017-0340-x PMID: 29038881

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

© Bentham Science Publishers, 2024